EP

Epi Biotech Co., Ltd.

Developing alopecia therapies, skin regeneration products, and preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Epi Biotech Co., Ltd. is an advanced biopharmaceutical company specializing in the research and development of treatments for alopecia (hair loss). The company focuses on developing a pipeline of innovative cell and antibody therapies to meet the demand for hair restoration. It also provides preclinical Contract Research Organization (CRO) services for hair loss studies. Additionally, Epi Biotech conducts R&D in skin regeneration treatments with the goal of creating commercially viable consumer products. The company leverages what it describes as South Korea's largest alopecia genomic database to support its research efforts.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Epi Biotech Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 20.6 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway ULTI
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan 4559
株式会社PRISM BioLab Logo
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
Japan 206A

Talk to a Data Expert

Have a question? We'll get back to you promptly.